SNY Jan 2025 52.500 call
| Previous Close | 2.3000 |
| Open | 1.7300 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 52.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 1.7300 - 2.3000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1.1k |
GuruFocus.comSanofi SA's Dividend Analysis
Sanofi SA (NASDAQ:SNY) recently announced a dividend of $2.04 per share, payable on 2024-06-06, with the ex-dividend date set for 2024-05-09. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Sanofi SAs dividend performance and assess its sustainability.
BloombergBofA, BNP Poised to Win Lead Roles on $20 Billion Sanofi Spinoff
(Bloomberg) -- Bank of America Corp. and BNP Paribas SA are on the verge of winning lead roles arranging Sanofi’s separation of its consumer-health business, according to people familiar with the matter, in one of the year’s most sought-after banking assignments. Most Read from BloombergIsrael Says a Cease-Fire Plan Backed by Hamas Falls Far ShortAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeEx-Trump Controller Says Cohen Repaid From Personal AccountJack Dorsey Leaves Bluesky B
Insider MonkeyRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
